Preclinical CRO Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032

CHAPTER 1. Industry Overview of Preclinical CRO Market

1.1. Definition and Scope

1.1.1. Definition of Preclinical CRO

1.1.2. Market Segmentation

1.1.3. Years Considered for the Study

1.1.4. Assumptions and Acronyms Used

1.1.4.1. Market Assumptions and Market Forecast

1.1.4.2. Acronyms Used in Global Preclinical CRO Market

1.2. Summary

1.2.1. Executive Summary 

1.2.2. Preclinical CRO Market By Service

1.2.3. Preclinical CRO Market By Model Type

1.2.4. Preclinical CRO Market By End-Use

1.2.5. Preclinical CRO Market By Region

CHAPTER 2. Research Approach

2.1. Methodology 

2.1.1. Research Programs

2.1.2. Market Size Estimation

2.1.3. Market Breakdown and Data Triangulation

2.2. Data Source

2.2.1. Secondary Sources

2.2.2. Primary Sources

CHAPTER 3. Market Dynamics And Competition Analysis

3.1. Market Drivers

3.1.1. Driver 1

3.1.2. Driver 2

3.2. Restraints and Challenges

3.2.1. Restraint 1

3.2.2. Restraint 2

3.3. Growth Opportunities

3.3.1. Opportunity 1

3.3.2. Opportunity 2 

3.4. Porter’s Five Forces Analysis

3.4.1. Bargaining Power of Suppliers

3.4.2. Bargaining Power of Buyers

3.4.3. Threat of Substitute

3.4.4. Threat of New Entrants

3.4.5. Degree of Competition

3.5. Market Concentration Ratio and Market Maturity Analysis of Preclinical CRO Market

3.5.1. Go To Market Strategy

3.5.1.1. Introduction

3.5.1.2. Growth

3.5.1.3. Maturity

3.5.1.4. Saturation

3.5.1.5. Possible Development

3.6. Technological Roadmap for Preclinical CRO Market

3.7. Value Chain Analysis

3.7.1. List of Key Manufacturers 

3.7.2. List of Customers

3.7.3. Level of Integration

3.8. Cost Structure Analysis

3.8.1. Price Trend of Key Raw Materials

3.8.2. Raw Material Suppliers

3.8.3. Proportion of Manufacturing Cost Structure

3.8.3.1. Raw Material

3.8.3.2. Labor Cost

3.8.3.3. Manufacturing Expense

3.9. Regulatory Compliance

3.10. Competitive Landscape, 2022

3.10.1. Player Positioning Analysis

3.10.2. Key Strategies Adopted By Leading Players

CHAPTER 4. Manufacturing Plant Analysis

4.1. Manufacturing Plant Platform Height and Establish Date of Major Manufacturers in 2022

4.2. R&D Status of Major Manufacturers in 2022

CHAPTER 5. Preclinical CRO Market By Service

5.1. Introduction

5.2. Preclinical CRO Revenue By Service

5.2.1. Preclinical CRO Revenue (USD Million) and Forecast, By Service, 2020-2032

5.2.2. Bioanalysis and DMPK studies

5.2.2.1. Bioanalysis and DMPK studies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.2. In vitro ADME

5.2.2.2.1. In vitro ADME Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.2.3. In-vivo PK

5.2.2.3.1. In-vivo PK Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3. Toxicology Testing

5.2.3.1. Toxicology Testing Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.2. GLP

5.2.3.2.1. GLP Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.3.3. Non-GLP

5.2.3.3.1. Non-GLP Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4. Compound Management

5.2.4.1. Compound Management Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.2. Process R&D

5.2.4.2.1. Process R&D Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.3. Custom Synthesis

5.2.4.3.1. Custom Synthesis Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.4.4. Others

5.2.4.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5. Chemistry

5.2.5.1. Chemistry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.2. Medicinal Chemistry

5.2.5.2.1. Medicinal Chemistry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.5.3. Computation Chemistry

5.2.5.3.1. Computation Chemistry Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.6. Safety Pharmacology

5.2.6.1. Safety Pharmacology Market Revenue (USD Million) and Growth Rate (%), 2020-2032

5.2.7. Others

5.2.7.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 6. Preclinical CRO Market By Model Type

6.1. Introduction

6.2. Preclinical CRO Revenue By Model Type

6.2.1. Preclinical CRO Revenue (USD Million) and Forecast, By Model Type, 2020-2032

6.2.2. Patient Derived Organoid (PDO) Model

6.2.2.1. Patient Derived Organoid (PDO) Model Market Revenue (USD Million) and Growth Rate (%), 2020-2032

6.2.3. Patient Derived Xenograft Model

6.2.3.1. Patient Derived Xenograft Model Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 7. Preclinical CRO Market By End-Use

7.1. Introduction

7.2. Preclinical CRO Revenue By End-Use

7.2.1. Preclinical CRO Revenue (USD Million) and Forecast, By End-Use, 2020-2032

7.2.2. Biopharmaceutical Companies

7.2.2.1. Biopharmaceutical Companies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.3. Government and Academic Institutes

7.2.3.1. Government and Academic Institutes Market Revenue (USD Million) and Growth Rate (%), 2020-2032

7.2.4. Medical Device Companies

7.2.4.1. Medical Device Companies Market Revenue (USD Million) and Growth Rate (%), 2020-2032

CHAPTER 8. North America Preclinical CRO Market By Country 

8.1. North America Preclinical CRO Market Overview

8.2. U.S.

8.2.1. U.S. Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

8.2.2. U.S. Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

8.2.3. U.S. Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.3. Canada

8.3.1. Canada Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

8.3.2. Canada Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

8.3.3. Canada Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

8.4. North America PEST Analysis

CHAPTER 9. Europe Preclinical CRO Market By Country

9.1. Europe Preclinical CRO Market Overview

9.2. U.K.

9.2.1. U.K. Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

9.2.2. U.K. Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

9.2.3. U.K. Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.3. Germany

9.3.1. Germany Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

9.3.2. Germany Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

9.3.3. Germany Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.4. France

9.4.1. France Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

9.4.2. France Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

9.4.3. France Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.5. Spain

9.5.1. Spain Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

9.5.2. Spain Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

9.5.3. Spain Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.6. Rest of Europe

9.6.1. Rest of Europe Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

9.6.2. Rest of Europe Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

9.6.3. Rest of Europe Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

9.7. Europe PEST Analysis

CHAPTER 10. Asia Pacific Preclinical CRO Market By Country

10.1. Asia Pacific Preclinical CRO Market Overview

10.2. China

10.2.1. China Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.2.2. China Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.2.3. China Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.3. Japan

10.3.1. Japan Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.3.2. Japan Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.3.3. Japan Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.4. India

10.4.1. India Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.4.2. India Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.4.3. India Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.5. Australia

10.5.1. Australia Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.5.2. Australia Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.5.3. Australia Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.6. South Korea

10.6.1. South Korea Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.6.2. South Korea Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.6.3. South Korea Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.7. Rest of Asia-Pacific

10.7.1. Rest of Asia-Pacific Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

10.7.2. Rest of Asia-Pacific Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

10.7.3. Rest of Asia-Pacific Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

10.8. Asia-Pacific PEST Analysis

CHAPTER 11. Latin America Preclinical CRO Market By Country

11.1. Latin America Preclinical CRO Market Overview

11.2. Brazil

11.2.1. Brazil Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

11.2.2. Brazil Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

11.2.3. Brazil Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.3. Mexico

11.3.1. Mexico Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

11.3.2. Mexico Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

11.3.3. Mexico Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.4. Rest of Latin America

11.4.1. Rest of Latin America Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

11.4.2. Rest of Latin America Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

11.4.3. Rest of Latin America Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

11.5. Latin America PEST Analysis

CHAPTER 12. Middle East & Africa Preclinical CRO Market By Country 

12.1. Middle East & Africa Preclinical CRO Market Overview

12.2. GCC

12.2.1. GCC Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

12.2.2. GCC Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

12.2.3. GCC Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.3. South Africa

12.3.1. South Africa Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

12.3.2. South Africa Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

12.3.3. South Africa Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.4. Rest of Middle East & Africa

12.4.1. Rest of Middle East & Africa Preclinical CRO Revenue (USD Million) and Forecast By Service, 2020-2032

12.4.2. Rest of Middle East & Africa Preclinical CRO Revenue (USD Million) and Forecast By Model Type, 2020-2032

12.4.3. Rest of Middle East & Africa Preclinical CRO Revenue (USD Million) and Forecast By End-Use, 2020-2032

12.5. Middle East & Africa PEST Analysis

CHAPTER 13. Player Analysis Of Preclinical CRO Market

13.1. Preclinical CRO Market Company Share Analysis

13.2. Competition Matrix

13.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment

13.2.2. New Product Launches and Product Enhancements

13.2.3. Mergers And Acquisition In Global Preclinical CRO Market

13.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements

CHAPTER 14. Company Profile

14.1. Crown Bioscience

14.1.1. Company Snapshot

14.1.2. Business Overview

14.1.3. Financial Overview

14.1.3.1. Revenue (USD Million), 2022

14.1.3.2. Crown Bioscience 2022 Preclinical CRO Business Regional Distribution

14.1.4. Product /Service and Specification

14.1.5. Recent Developments & Business Strategy

14.2. Charles River Laboratories International, Inc.

14.3. Eurofins Scientific SE

14.4. Intertek Group plc (IGP)

14.5. LabCorp

14.6. Medpace Holdings, Inc.

14.7. PPD (Thermo Fisher Scientific, Inc.)

14.8. PRA Health Sciences, Inc. (ICON plc)

14.9. SGA SA

14.10. WuXi AppTec, Inc. (WAI)